{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T13:14:41Z","timestamp":1775222081556,"version":"3.50.1"},"reference-count":47,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":191,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101097094"],"award-info":[{"award-number":["101097094"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background\/aim<\/jats:title>\n                    <jats:p>Multiple Myeloma (MM) is the second most common blood cancer, characterised by the accumulation of malignant plasma cells and the production of large amounts of a monoclonal immunoglobulin protein, in the bone marrow. The identification and progression\/behaviour of molecular markers across stages remains a scientific challenge. This work aims to provide a holistic approach in the understanding of the disease progression through a computational approach, capable of characterising and distinguishing disease stages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"materials-methods\">\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Stage-stratified MM transcriptomic datasets were used to mine stage-specific information and calculate key entities at the gene level by means of: (a) differentially expressed genes (DEGs), (b) monotonically expressed genes (MEGs), (c) ratios of MEG-related pairs of genes (RMEGs). The performance of the RMEGs across samples has been investigated regarding their ability to characterize and discriminate the MM stages. The genes participating in the top-ranked RMEGs were further used for pathway enrichment analysis to further enlighten the functional understanding per MM stage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We show that the proposed computational methodology by means of RMEGs reveals short lists of key genes across stages, which in turn highlight significant groups of pathways associated with regulation and cell cycle.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusion\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We integrate the traditional analysis of DEGs with the concepts of MEGs and RMEGs, creating a novel computational approach capable of identifying key genes and pathways that can serve as a highly-filtered pool of candidate MM stage identification markers for further experimental investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.csbj.2025.07.017","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:08:12Z","timestamp":1752610092000},"page":"3090-3098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stage-specific gene pair ratios highlight genes and mechanisms related to presymptomatic and symptomatic Multiple Myeloma"],"prefix":"10.34133","volume":"27","author":[{"given":"Grigoris","family":"Georgiou","sequence":"first","affiliation":[{"name":"Bioinformatics Department, The Cyprus Institute of Neurology & Genetics, 6 International Airport Avenue, 2370, P.O.Box 23462, Nicosia 1683, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Minadakis","sequence":"additional","affiliation":[{"name":"Bioinformatics Department, The Cyprus Institute of Neurology & Genetics, 6 International Airport Avenue, 2370, P.O.Box 23462, Nicosia 1683, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nestoras","family":"Karathanasis","sequence":"additional","affiliation":[{"name":"Bioinformatics Department, The Cyprus Institute of Neurology & Genetics, 6 International Airport Avenue, 2370, P.O.Box 23462, Nicosia 1683, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyriaki","family":"Savva","sequence":"additional","affiliation":[{"name":"Bioinformatics Department, The Cyprus Institute of Neurology & Genetics, 6 International Airport Avenue, 2370, P.O.Box 23462, Nicosia 1683, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efi","family":"Athieniti","sequence":"additional","affiliation":[{"name":"Bioinformatics Department, The Cyprus Institute of Neurology & Genetics, 6 International Airport Avenue, 2370, P.O.Box 23462, Nicosia 1683, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilena M.","family":"Bourdakou","sequence":"additional","affiliation":[{"name":"Bioinformatics Department, The Cyprus Institute of Neurology & Genetics, 6 International Airport Avenue, 2370, P.O.Box 23462, Nicosia 1683, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George M.","family":"Spyrou","sequence":"additional","affiliation":[{"name":"Bioinformatics Department, The Cyprus Institute of Neurology & Genetics, 6 International Airport Avenue, 2370, P.O.Box 23462, Nicosia 1683, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5644\/ama2006-124.242","article-title":"Multiple Myeloma genomics - a concise review","volume":"48","author":"Castaneda O.","year":"2019","unstructured":"Castaneda O. and Baz R.: Multiple Myeloma genomics - a concise review. Acta Med Acad 2019; 48: 57.","journal-title":"Acta Med Acad"},{"key":"e_1_3_5_3_2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.21873\/cgp.20295","article-title":"Colon cancer progression is reflected to monotonic differentiation in gene expression and pathway deregulation facilitating stage-specific drug repurposing","volume":"18","author":"Bourdakou M.M.","year":"2021","unstructured":"Bourdakou M.M., Spyrou G.M. and Kolios G.: Colon cancer progression is reflected to monotonic differentiation in gene expression and pathway deregulation facilitating stage-specific drug repurposing. Cancer Genom Proteom 2021; 18: 757.","journal-title":"Cancer Genom Proteom"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/30.1.207"},{"key":"e_1_3_5_5_2","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","article-title":"GEOquery: a bridge between the gene expression omnibus (GEO) and BioConductor","volume":"23","author":"Davis S.","year":"2007","unstructured":"Davis S. and Meltzer P.S.: GEOquery: a bridge between the gene expression omnibus (GEO) and BioConductor. Bioinforma Oxf Engl 2007; 23: 1846.","journal-title":"Bioinforma Oxf Engl"},{"key":"e_1_3_5_6_2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/gcc.20668","article-title":"A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect","volume":"48","author":"Agnelli L.","year":"2009","unstructured":"Agnelli L., Mosca L., Fabris S. et al: A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect. Genes Chromosomes Cancer 2009; 48: 603.","journal-title":"Genes Chromosomes Cancer"},{"key":"e_1_3_5_7_2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13045-023-01472-y","article-title":"A gene signature can predict risk of MGUS progressing to multiple myeloma","volume":"16","author":"Sun F.","year":"2023","unstructured":"Sun F., Cheng Y., Ying J. et al: A gene signature can predict risk of MGUS progressing to multiple myeloma. J Hematol Oncol J Hematol Oncol 2023; 16: 70.","journal-title":"J Hematol Oncol J Hematol Oncol"},{"key":"e_1_3_5_8_2","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3324\/haematol.2013.087809","article-title":"Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies","volume":"99","author":"L\u00f3pez-Corral L.","year":"2014","unstructured":"L\u00f3pez-Corral L., Corchete L.A., Sarasquete M.E. et al: Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies. Haematologica 2014; 99: 1365.","journal-title":"Haematologica"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-037077"},{"key":"e_1_3_5_10_2","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1158\/0008-5472.CAN-06-4046","article-title":"Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling","volume":"67","author":"Chng W.J.","year":"2007","unstructured":"Chng W.J., Kumar S., Vanwier S. et al: Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling. Cancer Res 2007; 67: 2982.","journal-title":"Cancer Res"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007"},{"key":"e_1_3_5_12_2","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Gordon K.Smyth","year":"2004","unstructured":"Gordon K.Smyth: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3.","journal-title":"Stat Appl Genet Mol Biol"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.4103\/aca.ACA_157_18"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/52.3-4.591"},{"key":"e_1_3_5_15_2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/158520c0","article-title":"The coefficient of variation","volume":"158","author":"Kesteven G.L.","year":"1946","unstructured":"Kesteven G.L.: The coefficient of variation. Nature 1946; 158: 520.","journal-title":"Nature"},{"key":"e_1_3_5_16_2","first-page":"329","volume":"327","author":"Mann\u2013Whitney Test","year":"2008","unstructured":"Mann\u2013Whitney Test : Concise Encycl Stat 2008; 327: 329.","journal-title":"Concise Encycl Stat"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010920819831"},{"key":"e_1_3_5_19_2","unstructured":"Wajid Jawaid. enrichR: Provides an R Interface to \u2018Enrichr\u2019; 2023."},{"key":"e_1_3_5_20_2","article-title":"Cancer Stat Facts: Myeloma","author":"National Cancer Institute","year":"2024","unstructured":"National Cancer Institute : Cancer Stat Facts: Myeloma. Natl Cancer Inst 2024; .","journal-title":"Natl Cancer Inst"},{"key":"e_1_3_5_21_2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3390\/cells10020336","article-title":"Genetic abnormalities in multiple myeloma: prognostic and therapeutic implications","volume":"10","author":"Cardona-Benavides I.J.","year":"2021","unstructured":"Cardona-Benavides I.J., de Ram\u00f3n C. and Guti\u00e9rrez N.C.: Genetic abnormalities in multiple myeloma: prognostic and therapeutic implications. Cells 2021; 10: 336.","journal-title":"Cells"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.122"},{"key":"e_1_3_5_23_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2024.101168","article-title":"Chromosomal defects in multiple myeloma","volume":"64","author":"Clarke S.E.","year":"2024","unstructured":"Clarke S.E., Fuller K.A. and Erber W.N.: Chromosomal defects in multiple myeloma. Blood Rev 2024; 64: 101168.","journal-title":"Blood Rev"},{"key":"e_1_3_5_24_2","unstructured":"Anderson G. Plasma membrane profiling of multiple myeloma and the identification of novel monoclonal antibody targets; 2019."},{"key":"e_1_3_5_25_2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3324\/haematol.2010.033456","article-title":"A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines","volume":"96","author":"Moreaux J.","year":"2011","unstructured":"Moreaux J., Klein B., Bataille R. et al: A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines. Haematologica 2011; 96: 574.","journal-title":"Haematologica"},{"key":"e_1_3_5_26_2","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3298","article-title":"Assessment of ADCY9 polymorphisms and colorectal cancer risk in the Chinese Han population","volume":"23","author":"Li H.","year":"2021","unstructured":"Li H., Liu Y., Liu J. et al: Assessment of ADCY9 polymorphisms and colorectal cancer risk in the Chinese Han population. J Gene Med 2021; 23: e3298.","journal-title":"J Gene Med"},{"key":"e_1_3_5_27_2","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.21037\/jtd-22-1027","article-title":"ADCY9 functions as a novel cancer suppressor gene in lung adenocarcinoma","volume":"15","author":"Tang Y.","year":"2023","unstructured":"Tang Y., Wang T., Zhang A. et al: ADCY9 functions as a novel cancer suppressor gene in lung adenocarcinoma. J Thorac Dis 2023; 15: 1018.","journal-title":"J Thorac Dis"},{"key":"e_1_3_5_28_2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3389\/fonc.2020.01450","article-title":"A case-control study of ADCY9 gene polymorphisms and the risk of hepatocellular carcinoma in the Chinese Han population","volume":"10","author":"Chao X.","year":"2020","unstructured":"Chao X., Jia Y., Feng X. et al: A case-control study of ADCY9 gene polymorphisms and the risk of hepatocellular carcinoma in the Chinese Han population. Front Oncol 2020; 10: 1450.","journal-title":"Front Oncol"},{"key":"e_1_3_5_29_2","first-page":"16","article-title":"cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance","volume":"8","author":"Wang Y.","year":"2018","unstructured":"Wang Y., Tang Y., Hang H. et al: cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance. Am J Cancer Res 2018; 8: 16.","journal-title":"Am J Cancer Res"},{"key":"e_1_3_5_30_2","first-page":"2966","article-title":"Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis","volume":"190","author":"Heuck C.J.","year":"2013","unstructured":"Heuck C.J., Mehta J., Bhagat T. et al: Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis. J Immunol Baltim Md 1950 2013; 190: 2966.","journal-title":"J Immunol Baltim Md 1950"},{"key":"e_1_3_5_31_2","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.872441","article-title":"Immune Microenvironment Terms Signature Robustly Predicts the Prognosis and Immunotherapy Response in Bladder Cancer Based on Large Population Cohorts","volume":"13","author":"Liang S.","year":"2022","unstructured":"Liang S., Fang K., Li S. et al: Immune Microenvironment Terms Signature Robustly Predicts the Prognosis and Immunotherapy Response in Bladder Cancer Based on Large Population Cohorts. Front Genet 2022; 13: 872441.","journal-title":"Front Genet"},{"key":"e_1_3_5_32_2","first-page":"4599305","article-title":"Identification of biomarkers associated with cancerous change in oral leukoplakia based on integrated transcriptome analysis","volume":"2022","author":"Li C.","year":"2022","unstructured":"Li C., Shi Y., Zuo L. et al: Identification of biomarkers associated with cancerous change in oral leukoplakia based on integrated transcriptome analysis. J Oncol 2022; 2022: 4599305.","journal-title":"J Oncol"},{"key":"e_1_3_5_33_2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41598-023-27531-5","article-title":"Expression of LIM domain-binding 3 (LDB3), a striated muscle Z-band alternatively spliced PDZ-motif protein in the nervous system","volume":"13","author":"Blech-Hermoni Y.","year":"2023","unstructured":"Blech-Hermoni Y., Subedi K., Silver M. et al: Expression of LIM domain-binding 3 (LDB3), a striated muscle Z-band alternatively spliced PDZ-motif protein in the nervous system. Sci Rep 2023; 13: 270.","journal-title":"Sci Rep"},{"key":"e_1_3_5_34_2","doi-asserted-by":"crossref","unstructured":"Li J. Dong J. Li M. et al. Potential mechanisms for predicting comorbidity between multiple myeloma and femoral head necrosis based on multiple bioinformatics; 2023.","DOI":"10.21203\/rs.3.rs-3792368\/v1"},{"key":"e_1_3_5_35_2","doi-asserted-by":"crossref","first-page":"8630","DOI":"10.1002\/jcb.28151","article-title":"An 11-gene-based prognostic signature for uveal melanoma metastasis based on gene expression and DNA methylation profile","volume":"120","author":"Li Y.","year":"2019","unstructured":"Li Y., Yang X., Yang J. et al: An 11-gene-based prognostic signature for uveal melanoma metastasis based on gene expression and DNA methylation profile. J Cell Biochem 2019; 120: 8630.","journal-title":"J Cell Biochem"},{"key":"e_1_3_5_36_2","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/abbs\/gmab128","article-title":"Quercetin inhibits the proliferation of multiple myeloma cells by upregulating PTPRR expression","volume":"53","author":"Wang H.","year":"2021","unstructured":"Wang H., Yu D., Zhang H. et al: Quercetin inhibits the proliferation of multiple myeloma cells by upregulating PTPRR expression. Acta Biochim Biophys Sin 2021; 53: 1505.","journal-title":"Acta Biochim Biophys Sin"},{"key":"e_1_3_5_37_2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-0-387-48894-3_8","article-title":"Multiple Myeloma","author":"Erba P.A.","year":"2013","unstructured":"Erba P.A. and Sollini M.: Multiple Myeloma. Nucl Oncol Pathophysiol Clin Appl 2013; : 189.","journal-title":"Nucl Oncol Pathophysiol Clin Appl"},{"key":"e_1_3_5_38_2","doi-asserted-by":"crossref","first-page":"1026153","DOI":"10.3389\/fonc.2022.1026153","article-title":"Systematic discrimination of the repetitive genome in proximity of ferroptosis genes and a novel prognostic signature correlating with the oncogenic lncRNA CRNDE in multiple myeloma","volume":"12","author":"Qin J.","year":"2022","unstructured":"Qin J., Sharma A., Wang Y. et al: Systematic discrimination of the repetitive genome in proximity of ferroptosis genes and a novel prognostic signature correlating with the oncogenic lncRNA CRNDE in multiple myeloma. Front Oncol 2022; 12: 1026153.","journal-title":"Front Oncol"},{"key":"e_1_3_5_39_2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/bjh.12964","article-title":"The spectrum of somatic mutations in high-risk acute myeloid leukaemia with -7\/del(7q)","volume":"166","author":"McNerney M.E.","year":"2014","unstructured":"McNerney M.E., Brown C.D., Peterson A.L. et al: The spectrum of somatic mutations in high-risk acute myeloid leukaemia with -7\/del(7q). Br J Haematol 2014; 166: 550.","journal-title":"Br J Haematol"},{"key":"e_1_3_5_40_2","first-page":"1","article-title":"Orphan peripheral neuropathies","volume":"8","author":"Finsterer J.","year":"2021","unstructured":"Finsterer J., L\u00f6scher W.N., Wanschitz J. et al: Orphan peripheral neuropathies. J Neuromuscul Dis 2021; 8: 1.","journal-title":"J Neuromuscul Dis"},{"key":"e_1_3_5_41_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00277-023-05520-y","article-title":"CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy","volume":"103","author":"Al Barashdi M.A.S.","year":"2024","unstructured":"Al Barashdi M.A.S., Ali A., McMullin M.F. et al: CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy. Ann Hematol 2024; 103: 73.","journal-title":"Ann Hematol"},{"key":"e_1_3_5_42_2","article-title":"Bone marrow interstitial light-chain amyloid and its microenvironment","volume":"142","author":"Zhou P.","year":"2023","unstructured":"Zhou P., Karagiannis T., Tai A. et al: Bone marrow interstitial light-chain amyloid and its microenvironment. Blood 2023; 142. :3317\u20133317.","journal-title":"Blood"},{"key":"e_1_3_5_43_2","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.3390\/cancers15164155","article-title":"Understanding DNA damage response and DNA repair in Multiple Myeloma","volume":"15","author":"Petrilla C.","year":"2023","unstructured":"Petrilla C., Galloway J., Kudalkar R. et al: Understanding DNA damage response and DNA repair in Multiple Myeloma. Cancers 2023; 15: 4155.","journal-title":"Cancers"},{"key":"e_1_3_5_44_2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/ijms19010040","article-title":"Decitabine and melphalan fail to reactivate p73 in p53 deficient Myeloma cells","volume":"19","author":"Gillardin P.-S.","year":"2017","unstructured":"Gillardin P.-S., Descamps G., Maiga S. et al: Decitabine and melphalan fail to reactivate p73 in p53 deficient Myeloma cells. Int J Mol Sci 2017; 19: 40.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_5_45_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00277-009-0818-3","article-title":"DNA methylation analysis of tumor suppressor genes in monoclonal gammopathy of undetermined significance","volume":"89","author":"Stanganelli C.","year":"2010","unstructured":"Stanganelli C., Arbelbide J., Fantl D.B. et al: DNA methylation analysis of tumor suppressor genes in monoclonal gammopathy of undetermined significance. Ann Hematol 2010; 89: 191.","journal-title":"Ann Hematol"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000358"},{"key":"e_1_3_5_47_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40164-020-00164-4","article-title":"Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma","volume":"9","author":"Zhang X.Y.","year":"2020","unstructured":"Zhang X.Y., Rajagopalan D., Chung T.-H. et al: Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma. Exp Hematol Oncol 2020; 9: 8.","journal-title":"Exp Hematol Oncol"},{"key":"e_1_3_5_48_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41420-020-00400-0","article-title":"Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis","volume":"7","author":"Ishiguro K.","year":"2021","unstructured":"Ishiguro K., Kitajima H., Niinuma T. et al: Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis. Cell Death Discov 2021; 7: 7.","journal-title":"Cell Death Discov"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037025002831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037025002831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2025.07.017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:33:38Z","timestamp":1775219618000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2025.07.017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":47,"alternative-id":["10.1016\/j.csbj.2025.07.017"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2025.07.017","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stage-specific gene pair ratios highlight genes and mechanisms related to presymptomatic and symptomatic Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2025.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}